SCHEMBL30779646

SCHEMBL30779646

CC(C)(O)c1ccc(OCc2ccccc2)cc1OCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.50
LMNA P02545 1/20 0.49
CYP1A2 P05177 1/20 0.49
PTGS1 P23219 1/20 0.49
SLC6A2 P23975 1/20 0.49
CYP2C19 P33261 1/20 0.49
PTGS2 P35354 1/20 0.49
SLC6A3 Q01959 1/20 0.49
HIF1A Q16665 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49
MAOB P27338 7/20 0.48
MRGPRX4 Q96LA9 1/20 0.46
CYP4F2 P78329 1/20 0.45
CYP4A11 Q02928 1/20 0.45
NR4A2 P43354 2/20 0.44
PDK1 Q15118 1/20 0.44
PDK2 Q15119 1/20 0.44
PDK3 Q15120 1/20 0.44
PDK4 Q16654 1/20 0.44
ALOX5AP P20292 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4063734 1.00 ALOX5 (0.50) ALOX5LMNACYP1A2PTGS1SLC6A2
SCHEMBL3814033 0.85 ALOX5 (0.50) ALOX5LMNACYP1A2PTGS1SLC6A2
SCHEMBL20607841 0.84 MAOB (0.50) ALOX5LMNACYP1A2PTGS1SLC6A2
SCHEMBL12475641 0.82 CYP3A4 (0.44) ALOX5LMNACYP1A2PTGS1SLC6A2
SCHEMBL4640614 0.79 RXRA (0.53) MAOBMRGPRX4ALOX5APMAPT
SCHEMBL15477426 0.79 GPR132 (0.48) ALOX5LMNACYP1A2CYP2C19HIF1A
SCHEMBL22303460 0.77 ALOX5 (0.40) ALOX5MAOBMRGPRX4NR4A2ALOX5AP
SCHEMBL13412635 0.77 ALOX5 (0.63) ALOX5LMNACYP1A2PTGS1SLC6A2
SCHEMBL17024328 0.77 ALOX5 (0.47) ALOX5LMNACYP1A2PTGS1SLC6A2
SCHEMBL30628484 0.76 C5AR1 (0.49) LMNACYP1A2PTGS1SLC6A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111164074-B Heat shock protein 90 inhibitors 台北医学大学 2024-02-02 CN disclosed